24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Debiopharm
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:28
Intel to spin off networking group, stepping back from battle with Nvidia
21:04
Cyber unicorn Axonius acquires Cynerio in $180M deal to expand into healthcare security
19:05
Intel stock plunges as Tan warns foundry dreams could be scrapped
11:20
Intel’s new boss has no time for field of dreams
More stories
Buzz
Most popular
Daily
Weekly
1
Intel’s new boss has no time for field of dreams
2
Is Palo Alto Networks eyeing a SentinelOne takeover?
3
Intel stock plunges as Tan warns foundry dreams could be scrapped
4
Intel job cuts swell to 25,000 as CEO Tan plots costly turnaround
5
Datadog in talks to acquire Upwind for $1 billion
More news
Debiopharm
1 stories about Debiopharm
AI cancer treatment startup Nucleai raises $6.5 million in series A round
07.07.20
|
Meir Orbach
Nucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment